{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:13:38Z","timestamp":1759058018008,"version":"3.40.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":579,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.nrl.2013.12.022","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T05:32:23Z","timestamp":1395725543000},"page":"276-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cambios en las Subpoblaciones de Linfocitos B y T en el T\u00edtulo de Anticuerpos Anti-Acuaporina-4 tras el Tratamiento de un Brote Agudo con Inmunoglobulinas y Rituximab"],"prefix":"10.1016","volume":"30","author":[{"given":"C.","family":"de Andr\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Teijeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"S\u00e1nchez-Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2013.12.022_bib0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0010","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","article-title":"Current concept of neuromyelitos optica (NMO) and NMO spectrum disorders","volume":"84","author":"Jacob","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrl.2013.12.022_bib0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.nrl.2013.12.022_bib0020","first-page":"99","article-title":"Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays","volume":"15","author":"Waters","year":"2008","journal-title":"Int MS J"},{"key":"10.1016\/j.nrl.2013.12.022_bib0025","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2013.12.022_bib0030","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nrl.2013.12.022_bib0035","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nrl.2013.12.022_bib0040","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1352458508092811","article-title":"Neuromyleitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica","volume":"14","author":"Weinstock-Guttman","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrl.2013.12.022_bib0045","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.0b013e3182152881","article-title":"Long-term follow-up of patients with neuromyleitis optica after repeated therapy with rituximab","volume":"76","author":"Pellkofer","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2013.12.022_bib0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1352458512454771","article-title":"Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: Distinct from multiple sclerosis","volume":"19","author":"Quan","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrl.2013.12.022_bib0055","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.4049\/jimmunol.164.5.2782","article-title":"Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients","volume":"164","author":"Colombo","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0060","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis. An expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2013.12.022_bib0065","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00415-007-0509-8","article-title":"Revised diagnostic criteria for optic neuromyelitis (NMO): Application in a series of suspected patients","volume":"254","author":"Saiz","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0213-4853(10)70016-5","article-title":"Espectro cl\u00ednico asociado a anticuerpos contra acuaporina 4 (Ig-NMO)","volume":"25","author":"Blanco","year":"2010","journal-title":"Neurolog\u00eda"},{"key":"10.1016\/j.nrl.2013.12.022_bib0075","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0317167100053932","article-title":"Devic\u2019 neuromyelitis optica treated with intravenous gamma globulins (IVIG)","volume":"31","author":"Bakker","year":"2004","journal-title":"Can J Neurol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2009.04.009","volume":"212","author":"de Andr\u00e9es","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.clim.2009.09.008","article-title":"IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8 (+) T cells and decreases memory CD8(+) subset: A longitudinal 1-year study","volume":"34","author":"Aristimu\u00f1o","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","article-title":"Memory B cells in common variable immunodeficiency: Clinical associations and sex differences","volume":"128","author":"Sanchez-Ramon","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/1352458508100837","article-title":"Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder","volume":"15","author":"Bonnan","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrl.2013.12.022_bib0100","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.0b013e3181b879be","article-title":"Plasma exchange for acute attacks of CNS demyelination Predictors of improvement at 6 months","volume":"73","author":"Llufriu","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2013.12.022_bib0105","doi-asserted-by":"crossref","first-page":"601","DOI":"10.33588\/rn.3007.99622","article-title":"Tratamiento con plasma inmunoadsorci\u00f3n en brotes severos y prolongados de esclerosis m\u00faltiple maligna","volume":"30","author":"De Andr\u00e9s","year":"2000","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.clim.2009.04.002","article-title":"Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulate T-cell activation","volume":"132","author":"MacMillan","year":"2009","journal-title":"Clinical Immunol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0115","article-title":"Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: Experience in 10 patients","author":"Elsone","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrl.2013.12.022_bib0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquoporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Benet","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2006.06.031","article-title":"Accumulation of class switched IgD-IgM- memory B cells in the cerebrospinal fluid during neuroinflammation","volume":"180","author":"Cepok","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0130","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"B linage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation","volume":"59","author":"Meinl","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clim.2006.11.004","article-title":"CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis","volume":"123","author":"Jilek","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamaneurol.2013.668","article-title":"Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica Implication for cellular immune responses","volume":"70","author":"Kieseier","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.06.029","article-title":"Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients","volume":"180","author":"Cross","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0150","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.21363","article-title":"Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase i trial","volume":"63","author":"Bar-Or","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0155","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archneurol.2010.99","article-title":"Changes in B and T lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis","volume":"67","author":"Piccio","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10875-009-9335-3","article-title":"Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus myoclonus","volume":"30","author":"Pranzatelli","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.nrl.2013.12.022_bib0165","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/archneurol.2011.154","article-title":"Repetaed treatment with rituximab based on the assessment of pheripheral circulating memory B cells in patients with relapsing neuromyleitis optica over 2 years","volume":"68","author":"Kim","year":"2011","journal-title":"Arch Neurol"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485314000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485314000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:28:05Z","timestamp":1746160085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485314000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0213485314000176"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2013.12.022","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cambios en las Subpoblaciones de Linfocitos B y T en el T\u00edtulo de Anticuerpos Anti-Acuaporina-4 tras el Tratamiento de un Brote Agudo con Inmunoglobulinas y Rituximab","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2013.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}